About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pick Up Service

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

ADMA Biologics Inc - Common Stock (NQ:ADMA)

8.030 -0.030 (-0.37%)

Streaming Delayed Price Updated: 1:20 PM EDT, Jun 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ADMA Biologics Inc - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗

September 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

Via Benzinga

4 Stocks Insiders Are Selling ↗

August 20, 2021

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...

Via Benzinga

38 Stocks Moving In Monday's Mid-Day Session ↗

August 16, 2021

Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares climbed 34.5% to $3.3900 after the company announced plan to expand product portfolio with introduction of Painshield relief for...

Via Benzinga

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data ↗

August 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck ↗

August 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Why Is It Moving? Looking At ADMA Biologics's Price Action Today ↗

April 28, 2021

ADMA Biologics's Stock Price And Volume Action ADMA Biologics's (NASDAQ:

Via Benzinga

ADMA Biologics Breaks Downtrend And May Rally ↗

April 22, 2021

After a painful two months, shareholders of ADMA Biologics (NASDAQ:ADMA) may final...

Via Benzinga

ADMA Biologics Stock Gains On FDA Approval For Plasma Collection Facility ↗

August 16, 2021

The

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 16, 2021

Gainers ADMA Biologics (NASDAQ:ADMA) stock rose 18.79% to $1.77 during Monday's pre-market session. The company's market cap stands at $226.8 million. The company...

Via Benzinga

ADMA Biologics Inc (ADMA) Q2 2021 Earnings Call Transcript ↗

August 12, 2021

ADMA earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

10 Biggest Price Target Changes For Tuesday ↗

July 06, 2021

Keybanc boosted NVIDIA Corporation (NASDAQ: NVDA) price target from $775 to $950. NVIDIA shares rose 0.6% to $824.60 in pre-market trading. Goldman Sachs boosted American...

Via Benzinga

A Peek Into The Markets: US Stock Futures Gain Ahead of Manufacturing Data ↗

June 01, 2021

Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones gained 65 points in the previous session. Markets were closed Monday for the...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering ↗

August 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO ↗

July 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc...

Via Benzinga

5 Stocks To Watch For June 1, 2021 ↗

June 01, 2021

Some of the stocks that may grab investor focus today are: Wall Street expects Hewlett Packard Enterprise Co (NYSE: HPE) to post quarterly earnings at $0.42 per share on revenue...

Via Benzinga

ROCE Insights For ADMA Biologics ↗

May 28, 2021

During Q1, ADMA Biologics (NASDAQ:ADMA) brought in sales totaling $16.05 million. However, earnings decreased 11.94%, resulting in a loss of $15.16 million. In Q4, ADMA Biologics...

Via Benzinga

ADMA Biologics Inc (ADMA) Q1 2021 Earnings Call Transcript ↗

May 12, 2021

ADMA earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Recap: ADMA Biologics Q1 Earnings ↗

May 12, 2021

Shares of ADMA Biologics (NASDAQ:ADMA) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 38.46% over the...

Via Benzinga

ADMA Biologics Earnings Preview ↗

May 11, 2021

On Wednesday, May 12, ADMA Biologics (NASDAQ:ADMA) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release....

Via Benzinga

ADMA Stock: The Big FDA News Boosting ADMA Biologics Today ↗

April 28, 2021

Today, ADMA stock is a big mover as the company announced a very bullish FDA approval allowing the company to scale its core product.

Via InvestorPlace

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗

May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Via Benzinga

Earnings Scheduled For May 12, 2021 ↗

May 12, 2021

Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report...

Via Benzinga

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

ADMA Biologics Shares Jump On Increased Manufacturing Capacity For Intravenous Immune Globulin ↗

April 28, 2021

The FDA has approved ADMA Biologics Inc's (NASDAQ: ADMA) expanded manufacturing process, enabling fractionation and purification of a 4,400-liter plasma...

Via Benzinga

The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue ↗

April 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex ↗

April 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

ADMA Biologics Inc - Common Stock (NQ:ADMA)

All News about ADMA Biologics Inc - Common Stock

Sections

Services

Contact Information

Follow Us